Thermo Fisher Scientific Inc.

Present Value of Free Cash Flow to the Firm (FCFF)

The FCFF valuation approach estimates the value of the firm as the present value of future FCFF discounted at the weighted average cost of capital (WACC).

• Intrinsic Stock Value (Valuation Summary)
• Weighted Average Cost of Capital (WACC)
• FCFF Growth Rate (g)

Selected Financial Data
since 2005

Main items of Thermo Fisher Scientific Inc.'s financial statements.

• Income Statement
• Assets
• Liabilities and Stockholders' Equity
• Statement of Cash Flows
• Per Share Data

Liquidity Analysis
Quarterly Data

Measures the adequacy of a Thermo Fisher Scientific Inc.'s cash resources to meet its near-term cash obligations.

• Ratios (Summary)
• Current Ratio
• Quick Ratio
• Cash Ratio

Income Statement

The income statement (statement of earnings) reports on the performance of Thermo Fisher Scientific Inc., the result of its operating activities.

Statement of Financial Position, Assets
Quarterly Data

The assets reports major classes and amounts of resources owned or controlled by Thermo Fisher Scientific Inc..

Enterprise Value to EBITDA (EV/EBITDA)

To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.

• Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
• EV to EBITDA Ratio, Current
• EV to EBITDA Ratio, Historical